Cited by 88Drug-Induced Hepatotoxicity and ProtectionLiver physiology and pathologyAcute Kidney Injury Research

Protein kinase C (PKC) participates in acetaminophen hepatotoxicity through c-jun-N-terminal kinase (JNK)-dependent and -independent signaling pathways

Open access
Saberi, Behnam, Ybanez, Maria D., Johnson, Heather S., Gaarde, William A., Han, Derick, Kaplowitz, Neil·2014·Hepatology

Abstract

UNLABELLED: This study examines the role of protein kinase C (PKC) and AMP-activated kinase (AMPK) in acetaminophen (APAP) hepatotoxicity. Treatment of primary mouse hepatocytes with broad-spectrum PKC inhibitors (Ro-31-8245, Go6983), protected against APAP cytotoxicity despite sustained c-jun-N-terminal kinase (JNK) activation. Broad-spectrum PKC inhibitor treatment enhanced p-AMPK levels and AMPK regulated survival-energy pathways including autophagy. AMPK inhibition by compound C or activation using an AMPK activator oppositely modulated APAP cytotoxicity, suggesting that p-AMPK and AMPK regulated energy survival pathways, particularly autophagy, play a critical role in APAP cytotoxicity. Ro-31-8245 treatment in mice up-regulated p-AMPK levels, increased autophagy (i.e., increased LC3-II formation, p62 degradation), and protected against APAP-induced liver injury, even in the presence of sustained JNK activation and translocation to mitochondria. In contrast, treatment of hepatocytes with a classical PKC inhibitor (Go6976) protected against APAP by inhibiting JNK activation. Knockdown of PKC-α using antisense (ASO) in mice also protected against APAP-induced liver injury by inhibiting JNK activation. APAP treatment resulted in PKC-α translocation to mitochondria and phosphorylation of mitochondrial PKC substrates. JNK 1 and 2 silencing in vivo decreased APAP-induced PKC-α translocation to mitochondria, suggesting PKC-α and JNK interplay in a feed-forward mechanism to mediate APAP-induced liver injury. CONCLUSION: PKC-α and other PKC(s) regulate death (JNK) and survival (AMPK) proteins, to modulate APAP-induced liver injury.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.26625

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Saberi, B., Ybanez, M. D., Johnson, H. S., Gaarde, W. A., Han, D., & Kaplowitz, N.
Affiliations
  • University of Southern California (US)
  • Ionis Pharmaceuticals (United States) (US)
  • Keck Graduate Institute (US)
Corresponding author
Kaplowitz, Neil
Venue
Hepatology
Published
2014-04
Volume
59
Issue
4
Pages
1543-1554
ISSN
0270-9139 (ISSN-L)
OpenAlex
W1576016712
Cited by
88
References
34
Citations by year
2026: 3 · 2025: 1 · 2024: 2 · 2023: 4 · 2022: 5 · 2021: 6 · 2020: 4 · 2019: 8 · 2018: 17 · 2017: 8 · 2016: 6 · 2015: 15 · 2014: 7 · 2013: 2
FWCI
10.91
Type
journal article
Language
en
Open access
Locations
  • Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (1s10rr022508-01a1)
  • University of California, San Francisco
  • National Institute on Alcohol Abuse and Alcoholism (K01AA016911, AA016911)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK067215, DK067215, P30DK048522)
  • National Center for Research Resources (S10-RR022508)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
Keywords
protein kinase C, acetaminophen hepatotoxicity, c-Jun N-terminal kinase, AMPK, protein kinase C alpha, autophagy, mitochondrial translocation, hepatocyte death, liver injury, JNK signaling, energy metabolism, PKC inhibitors
MeSH terms
Acetaminophen, Animals, Cells, Cultured, Disease Models, Animal, Indoles, Male, Maleimides, Mice, Inbred C57BL, Mitochondria, Liver, Necrosis, Protein Kinase C, Signal Transduction, Hepatocytes, Protein Kinase Inhibitors, JNK Mitogen-Activated Protein Kinases, Mice, AMP-Activated Protein Kinases, Chemical and Drug Induced Liver Injury, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review